Dyadic Co-learning Intervention for Patients With Prostate Cancer and Their Spouses
Development and Exploring the Efficacy of a Dyadic Co-learning Intervention for Patients With Prostate Cancer and Their Spouses
National Taipei University of Nursing and Health Sciences
60 participants
Oct 13, 2025
INTERVENTIONAL
Conditions
Summary
This study aims to help patients with prostate cancer and their spouses cope better with the challenges of cancer by learning and supporting each other together. The investigators will test an 8-week "Dyadic Co-learning Intervention," which includes weekly learning topics, a mobile app, and professional support. The goal is to improve their physical symptoms, emotional well-being, and resilience. Participants will be randomly assigned to one of two groups. One group will receive regular care, while the other group will receive regular care plus the new co-learning program. The investigators will ask both patients and their spouses to complete questionnaires at the beginning of the study, and again at 10 and 16 weeks, to understand how the program affects their health and well-being.
Eligibility
Inclusion Criteria7
- For Patients:
- Diagnosed with prostate cancer by a board-certified urologist.
- Has either decided on a treatment plan or completed treatment within the past two years.
- Has an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1.
- For Spouses:
- Must be a cohabiting spouse of the prostate cancer patient and aged 20 years or older.
- Must have a Barthel Index score of 91 or above, indicating good functional independence.
Exclusion Criteria3
- Either the patient or the spouse will be excluded if:
- Diagnosed with another type of cancer.
- Diagnosed with cognitive impairment or a psychiatric disorder, such as dementia, depression, or anxiety.
Interventions
Participants in the experimental group will receive routine care plus an 8-week Dyadic Co-learning Intervention, which will consist of three components: (1) a co-learning handbook, (2) a co-learning mobile app, and (3) professional support.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07196488